Home
About
Help
Alert
Account
Login
Advertisement
Advertisement
Back to Home
Search
Advanced
Find article
Advanced search
Clear all filters
Date
Past 5 Years
Past 10 Years
Published Between:
Full Text
0
Abstract available
0
Clinical Commentary available
0
Free full text available
2
Full text available
0
PICO Summary available
Clinical Specialty
0
Blood Donors and Donation Practice
0
Donor Care
0
Processing and Storage of Donated Products
0
Recruitment and Retention of Blood Donors
0
Critical Care
0
Burns
0
Neonatal Intensive Care
0
Non-Traumatic Haemorrhage
0
Sepsis
0
Trauma
4
Haematology and Oncology
0
Haematology, Malignant
4
Haematology, Non-Malignant
0
Oncology
0
Medicine
0
Autoimmune Diseases
0
COVID-19
0
Cardiovascular Disorders
0
Dermatology
0
Gastrointestinal Disorders
0
Hepatic and Biliary Diseases
0
Infectious Diseases
0
Kidney Diseases
0
Musculoskeletal Disorders
0
Neurology
0
Obstetrics and Gynaecology
0
Gynaecological and Obstetric Non-Surgery
0
Gynaecological and Obstetric Surgery
0
Surgery
0
Brain and Spinal Surgery
0
Cardiovascular Surgery
0
Dental and Maxillofacial Surgery
0
ENT and Eye Surgery
0
Gastro, Kidney and Liver Surgery
0
Genitourinary Surgery
0
Orthopaedic Surgery
Subject Area
4
Adverse Effects of Transfusion
0
Allergic Reactions
0
Febrile Non-Haemolytic Transfusion Reactions
0
Haemolytic Reactions
4
Iron Overload
0
Respiratory Complications
0
Transfusion Transmitted Infections
0
Uncommon Complications of Transfusion
0
Alternatives to Blood
0
Albumin
0
Antifibrinolytics
0
Autologous Transfusion and Cell Salvage
0
Drugs Stimulating Platelet Production
0
Gene Therapy
0
Management of Anaemia
0
Non-Drug Interventions
0
Other Drug Interventions
0
Recombinant Coagulation Factors
0
Red Cell Substitutes
0
Blood Components
0
Convalescent Plasma
0
Cryoprecipitate
0
Plasma/FFP
0
Platelet Related Components
0
Platelets
0
Red Cells
0
White Cells/Granulocytes
0
Whole Blood
0
Clinical Practice
0
Assessment of Abnormal Haemostasis
0
Errors and Near Misses
0
Measuring Blood Loss
0
Transfusion Education
0
Transfusion Practice
0
Fractionated Blood Products
0
Activated Protein C
0
Albumin
0
Anti-D IG
0
Factor VIII
0
Factor XIII
0
Fibrinogen Concentrate
0
Hyperimmune Immunoglobulin
0
Immunoglobulin G and IVIG
0
Prothrombin Complex Concentrate
0
Therapeutic Apheresis
0
Leucopheresis
0
Photopheresis
0
Plasmapheresis
0
Plateletpheresis
0
Red Cell Exchange
Study Design
4
Economic Study
Randomised Controlled Trial
Systematic Review
Results for
'author:"Sofrygin O"'
• 4 results
Sort by
Date
Relevance
Journal
Title
Reverse date
Select all
Clear all selections
0
selected
Print
Email
Save
1.
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective
Delea TE, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD
Pharmacoeconomics. 2007;25((4):):329-42.
Full text
Ovid Technologies, Inc.
Springer
2.
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review
Delea TE, Edelsberg J, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD
Transfusion. 2007;47((10):):1919-1929.
Full text
Ovid Technologies, Inc.
Wiley
3.
Chelation therapy with deferasirox versus deferoxamine in transfusion-dependent sickle-cell disease: a cost-effectiveness analysis from the US perspective
Delea T, Sofrygin O, Baladi J, Thomas SK, Coates TD
Haematologica. 2006;91((Suppl 1):): Abstract No. 0003.
4.
Sensitivity analysis of the cost-effectiveness of chelation therapy with deferasirox or deferoxamine in transfusion-dependent thalassemia patients based on European costs
Delea T, Sofrygin O, Baladi J, Thomas SK, Phatak PD, Coates TD
Haematologica. 2006;91((Suppl 1):): Abstract No. 0008.
Page 1 of 1 pages
◄
►